Alkermes Plc (NASDAQ:ALKS)

26.15
Delayed Data
As of Aug 12
 +0.68 / +2.67%
Today’s Change
21.24
Today|||52-Week Range
33.00
+12.42%
Year-to-Date
Here's Why You Should Buy Patterson Companies (PDCO) Stock
Aug 12 / Zacks.com - Paid Partner Content
3 Companies Growing Revenue Fast
Aug 10 / GuruFocus News - Paid Partner Content
Roche (RHHBY) Influenza Drug Gets FDA Nod for Children
Aug 12 / Zacks.com - Paid Partner Content
Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down
Aug 10 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Could Find Support Soon, Here's Why You Should Buy the Stock Now
Aug 11 / Zacks.com - Paid Partner Content
CONMED (CNMD) Acquires Soft Tissue Implant Start-Up Biorez
Aug 10 / Zacks.com - Paid Partner Content
Cardinal Health (CAH) Q4 Earnings Lag Estimates, Revenues Top
Aug 11 / Zacks.com - Paid Partner Content
Perrigo's (PRGO) Q2 Earnings Misses by a Cent, Sales Beat
Aug 09 / Zacks.com - Paid Partner Content
Allogene (ALLO) Q1 Earnings Beat, Pipeline Progressing Well
Aug 10 / Zacks.com - Paid Partner Content
Karuna (KRTX) Lags on Q2 Earnings, Up 71% on Schizophrenia Data
Aug 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close25.47
Today’s open25.73
Day’s range25.39 - 26.15
Volume108,388
Average volume (3 months)1,622,193
Market cap$4.3B
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)+57.13%
Earnings growth (this year)-73.60%
Earnings growth (next 5 years)+23.91%
Revenue growth (last year)+13.00%
P/E ratioNM
Price/Sales3.19
Price/Book3.80

Competitors

----
GBTGlobal Blood Therape...+0.16+0.24%
----
----
Data as of 3:59pm ET, 08/12/2022

Financials

Next reporting dateOctober 26, 2022
EPS forecast (this quarter)$0.03
Annual revenue (last year)$1.2B
Annual profit (last year)-$48.2M
Net profit margin-4.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Dublin, Dublin

Forecasts